Latest Breaking News On - Daewoong pharmaceuticals - Page 5 : comparemela.com

DoKaSch Temperature Solutions announces business expansion in Asia-Pacific region

Kevin Lee has assumed the position Sales & Business Development Manager South Korea with DoKaSch Temperature Solutions.

HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmaceuticals to Develop Therapy for Parkinson's Disease

/PRNewswire/ HanAll Biopharma Co., Ltd. (KRX: 009420.KS) and Daewoong Pharmaceutical Co., Ltd. (KRX: 069620.KS) announced that they have entered into a.

Botulinum Toxin Market to Reach Valuation of USD 13.4 Bn at

According to Market.us, The medicinal use of botulinum toxin in cosmetic procedures has expanded the range of beauty treatments by providing a safe and.

Avacta : Preliminary Results for the year ended 31 December 2022

A period of continued significant progress Avacta Group plc , a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, is pleased to. | April 25, 2023

Brand Institute Promotes Kurt Yoon, R.Ph., to Divisional President, Asia